The National Medical Weight Loss Programme (NMWLP) uses an FDA and NICE approved medication called Liraglutide, which is licensed for weight loss under the trade name Saxenda ®. It has passed numerous clinical trials for safety. It is the only approved injectable prescription medicine available in the UK for weight loss.

Liraglutide mimics the action of GLP-1 (a natural hormone produced by the body). This hormone regulates appetite and food intake. GLP-1 makes you feel full hence, it reduces your appetite. It also delays the time it takes for the stomach to empty, keeping you full and satisfied (sated) for longer. Both of these actions lead to lower calorie intake and subsequent weight loss.

By reducing your appetite, the Liraglutide will help you keep to the calorie-controlled diet of your choice. Weight Watchers, Slimming World, Ketogenic, Intermittent fasting to name but a few. The effects of your medication will enable you to easily adhere to your chosen eating plan.

Additionally, by losing weight you are reducing your risk of developing heart disease, high blood pressure, type 2 diabetes and more importantly, help you feel healthier, happier and more confident.

A simple and painless injection is self -administered each day using an easy to use, dose adjustable pen that is filled with the medication.

The NMWLP uses a medication that is prescribed for weight loss, and used in conjunction with diet and exercise in adults aged 18-75 who have a BM<I of 30 or above, or a BMI of 27 when there are any other weight-related health issues present such as high blood pressure, abnormal levels of fats in the blood (lipids), or breathing problems
 During sleep (obstructive sleep apnoea).

•    Pregnant, trying to get pregnant or breast feeding
•    Inflammatory bowel disease
•    History of thyroid cancer
•    History of pancreatitis
•    Severe kidney disease
•    Severe heart failure
•    Already taking a form of Insulin

As with any new medication, following the NMWLP may result in some short -term side effects. The most common side effects are nausea, indigestion, constipation, or diarrhoea.
However, these usually settle within the first few days. Please remember, our team are always on hand to answer any questions or concerns you may have.

Each pen contains 18mg of Liraglutide. Every patient starts on 0.6mg daily for the first week. If the desired outcomes are achieved on this dose i.e. not feeling hungry or craving certain foods (so you don’t cheat on your diet), this dose can be maintained. If on the other hand, your appetite is not fully controlled, the dose should be increased by up to 0.6mg per week. This pattern can be repeated each week until the desired effects are achieved, but only up to a maximum of 3.0mg daily.

ONE PEN CAN LAST UP TO 30 DAYS DEPENDING ON THE DAILY DOSE REQUIRED TO ACHIEVE THE DESIRED OUTCOMES.

The NMWLP uses a prescription medication, and you must complete a medical assessment to ensure it is safe for you to use it.

Simply call or email us to make an appointment or discuss any further questions you may have.